|
Dr. Cole has served on the journal editorial board from 1994-2001 as the Editor of "Trophoblast Disease Update". He has written more than 100 articles on hCG structure, physiology and immunoassay and on clinical applications of hCG or hCG-related molecules. He has a 1.17 FWCI in the Medicine category of SciVal where he has published throughout the various disciplines and maintains an average of 12.6 citations per article from 2009-2014. He has experience with international, single, and institutional collaboration. Awards and recognition for Dr. Cole include the Institute for Anticancer Research, Biannual Prize for best research; American Association for Clinical Chemistry, Most Outstanding Research Contributor to Clinical Chemistry Prize; Gynecology Oncology, Outstanding Speaker Award; and International Society for Study of Trophoblastic Disease, Gold Medal for most outstanding research. Dr. Kramer is a former research scientist and university professor (Lincoln College of New England, Southington CT) who founded Ingenium Patents LLC which specializes in providing services to inventors and companies developing new products. In addition to patent drafting and prosecution they conduct critical research into patent and non-patent literature required by R&D managers and technical personnel. Peter is admitted to practice before the United States Patent and Trademark Office. Dr. Kramer has been awarded the National Research Service Award, National Institutes of Health, USA. (1985) and National Science Foundation instrumentation grant, Principal Investigator (1992). He is a member of the American Chemical Society, AAAS, and Mensa. |
